Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
LIPELLA PHARMACEUTICALS INC.
| Metric | LIPELLA PHARMACEUTICALS INC. LIPOHealthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $536,357 |
| Net income (latest) | −$5M |
| Operating margin | −947.2% |
| Net margin | −935.2% |
| Return on equity | −261.3% |
| Return on assets | −187.6% |
| Return on capital (ROCE) | −264.7% |
| Debt / equity | 0.39× |
| Revenue growth (YoY) | 19.3% |
| Altman Z″ (distress) | -24.23 |
| Accruals / assets | −39.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.